Today CYTENA, a BICO company, announced it has signed a 2-year deal with Applitech Pharmaceutical Equipment Technology to distribute its single cell isolators in China. The deal worth more than USD 10 million will see nearly 100 of the company’s single cell isolators including the UP.SIGHT devices be distributed in the world’s second largest life science market. The deal advances BICO’s bio convergence agenda by accelerating the development of next generation treatments including gene therapies, biosimilars, and monoclonal antibodies.
“The life science market in China is one of the most impressive in the world and we’re thrilled with this deal to be able to help researchers there accelerate their life saving work,” said Erik Gatenholm, CEO and co-founder of BICO. “Applitech is the perfect partner to help us grow our market share at this pivotal time.”
